A Basket Trial of Vunakizumab in Inflammatory Skin Diseases

NCT ID: NCT06794671

Last Updated: 2025-01-27

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 10000 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-03-01
• Study Completion Date: 2031-12-31

Brief Summary

This is a national multi-center, large sample size case registration clinical study. The registry population was patients with inflammatory skin diseases who were receiving treatment with vunakizumab. All outpatient and inpatient patients with inflammatory skin diseases who were receiving vunakizumab were eligible for enrollment. Patients' usual care was not affected by participation in the study. We only collected data in routine clinical practice.

The study had an enrollment period of 5 years or 10,000 patients were recruited early, whichever occurred first. All patients must provide written informed consent form before data collection, and each patient will be followed for 1 year to observe clinical progression.

Conditions

Inflammatory Skin Diseases; Psoriasis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• aged ≥ years；
• had adiagnosis of inflammatory skin disease；
• Is receiving or plans to receive vunakizumab for treatment;
• Patients provided written informed consent form.

Exclusion Criteria

• no.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Central Contacts

Xiaoyong Man, PhD

Role: CONTACT

manxy@zju.edu.cn

86-0571-87783753

Wei Li, PhD

Role: CONTACT

Wei.Li@zju.edu.cn

Other Identifiers

2024-0999

Identifier Type: -

Identifier Source: org_study_id